Factors related to weight gain in patients with schizophrenia treated with serotonin-dopamine antagonists

被引：0
|
作者：
Jang, WSJ
Kim, SKK
Choi, KSC
Park, DYP
Han, WSH
Hong, KSH
Lee, DSL
机构：
[1] Samsung Med Ctr, Dept Psychiat, Seoul, South Korea
[2] St Andrew Neuropsychiat Hosp, Dept Psychiat, Ichon, South Korea
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2004年 / 14卷
关键词：
D O I：
10.1016/S0924-977X(04)80232-3
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S237 / S237
页数：1
相关论文
共 50 条
  • [11] TPN672: A Novel Serotonin-Dopamine Receptor Modulator for the Treatment of Schizophrenia
    Wang, Yu
    He, Yang
    Yang, Feipu
    Abame, Melkamu Alemu
    Wu, Chunhui
    Peng, Yanmin
    Feng, Linyin
    Shen, Jingshan
    Wang, Zhen
    He, Ling
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2021, 378 (01) : 20 - 30
  • [12] Serotonin-dopamine interactions in cognitive dysfunction: improving cognition in schizophrenia via serotonergic targets
    Meltzer, H.
    Snigdha, S.
    Li, Z.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 115 - 116
  • [13] GIPR Gene Polymorphism and Weight Gain in Patients With Schizophrenia Treated With Olanzapine
    Ono, Shin
    Suzuki, Yutaro
    Fukui, Naoki
    Sawamura, Kazushi
    Sugai, Takuro
    Watanabe, Junzo
    Tsuneyama, Nobuto
    Someya, Toshiyuki
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2015, 27 (02) : 162 - 164
  • [14] Are dopamine-related genotypes risk factors for excessive gestational weight gain?
    Goldfield, Gary S.
    Dowler, Lauren Marie
    Walker, Mark
    Cameron, Jameason D.
    Ferraro, Zachary M.
    Doucet, Eric
    Adamo, Kristi B.
    INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2013, 5 : 253 - 259
  • [15] Management of weight gain in patients with schizophrenia
    Aquila, R
    JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 : 33 - 36
  • [16] Effectiveness of Metformin for Weight Reduction in Children and Adolescents Treated with Mixed Dopamine and Serotonin Receptor Antagonists: A Naturalistic Cohort Study
    Levy-Shraga, Yael
    Madi, Lee Rima
    Shalev, Mor
    Mazor-Aronovitch, Kineret
    Schwartz-Lifshitz, Maya
    Gothelf, Doron
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2021, 31 (05) : 376 - 380
  • [17] EFFECT OF NEUROLEPTIC MEDICATION ON CEREBROSPINAL-FLUID MONOAMINE METABOLITE CONCENTRATIONS IN SCHIZOPHRENIA - SEROTONIN-DOPAMINE INTERACTIONS AS A TARGET FOR TREATMENT
    KAHN, RS
    DAVIDSON, M
    KNOTT, P
    STERN, RG
    APTER, S
    DAVIS, KL
    ARCHIVES OF GENERAL PSYCHIATRY, 1993, 50 (08) : 599 - 605
  • [18] Compulsive eating and weight gain related to dopamine agonist use
    Nirenberg, MJ
    Waters, C
    MOVEMENT DISORDERS, 2006, 21 (04) : 524 - 529
  • [19] Weight gain in patients with schizophrenia treated with risperidone, olanzapine, quetiapine or haloperidol:: results of the EIRE study
    Bobes, J
    Rejas, J
    Garcia-Garcia, M
    Rico-Villademoros, F
    García-Portilla, MP
    Fernández, I
    Hernández, G
    SCHIZOPHRENIA RESEARCH, 2003, 62 (1-2) : 77 - 88
  • [20] FACTORS RELATED TO WEIGHT GAIN OF DAIRY CALVES
    MARTIN, TG
    JACOBSON, NL
    MCGILLIARD, LD
    JOURNAL OF DAIRY SCIENCE, 1962, 45 (07) : 886 - &
12345